-
2
-
-
0025909369
-
Ranitidine in the treatment of duodenal ulcer disease: Relationships between antisecretory effect and ulcer healing rate
-
Mc Isaac RL, Dixon JS, Mills JG, Wood JR. Ranitidine in the treatment of duodenal ulcer disease: relationships between antisecretory effect and ulcer healing rate. Aliment Pharmacol Ther 1991; 5: 227-243.
-
(1991)
Aliment Pharmacol Ther
, vol.5
, pp. 227-243
-
-
Mc Isaac, R.L.1
Dixon, J.S.2
Mills, J.G.3
Wood, J.R.4
-
3
-
-
0025079459
-
La ranitidinc dans le traitement de l'oesophagite légère à modérée: Évaluation d'une forme soluble, le comprimé effervescent
-
Fournet J, Bourhis F, Alberola B, Pappo M. La ranitidinc dans le traitement de l'oesophagite légère à modérée: évaluation d'une forme soluble, le comprimé effervescent. Rev Fr Gastroenterol 1990; 26: 239-246.
-
(1990)
Rev Fr Gastroenterol
, vol.26
, pp. 239-246
-
-
Fournet, J.1
Bourhis, F.2
Alberola, B.3
Pappo, M.4
-
4
-
-
0027337811
-
Facteurs prédictifs de cicatrisation des oesophagites. Etude prospective en cours du traitement par la ranitidine
-
Fournet J, Ottignon Y, Alberola B. Facteurs prédictifs de cicatrisation des oesophagites. Etude prospective en cours du traitement par la ranitidine. La Presse Medicale 1993, 22: 1087-1090.
-
(1993)
La Presse Medicale
, vol.22
, pp. 1087-1090
-
-
Fournet, J.1
Ottignon, Y.2
Alberola, B.3
-
5
-
-
0024096950
-
A model of an 'artificial stomach' for assessing the characteristics of an antacid
-
Vatier J, Lionnet F, Vitré MT, Mignon M. A model of an 'artificial stomach' for assessing the characteristics of an antacid. Aliment Pharmacol Ther 1988; 2: 461-470.
-
(1988)
Aliment Pharmacol Ther
, vol.2
, pp. 461-470
-
-
Vatier, J.1
Lionnet, F.2
Vitré, M.T.3
Mignon, M.4
-
6
-
-
0026701667
-
An artificial stomach-duodenum model for the in vitro evaluation of an antacid
-
VatierJ, Malikova-Sekera E, Vitré MT, Mignon M. An artificial stomach-duodenum model for the in vitro evaluation of an antacid. Aliment Pharmacol Ther 1992; 6: 447-458.
-
(1992)
Aliment Pharmacol Ther
, vol.6
, pp. 447-458
-
-
VatierJ1
Malikova-Sekera, E.2
Vitré, M.T.3
Mignon, M.4
-
7
-
-
0001440290
-
Gastric and duodenal mucosal secretions
-
Johnson LR Ed. New York: Raven Press
-
Flemström G. Gastric and duodenal mucosal secretions. In: Johnson LR Ed. Physiology of the gastrointestinal tract, 2nd ed New York: Raven Press, 1987: 1011-1029.
-
(1987)
Physiology of the Gastrointestinal Tract, 2nd Ed
, pp. 1011-1029
-
-
Flemström, G.1
-
8
-
-
0022627980
-
Human duodenal mucosal bicarbonate secretion. Evidence for basal secretion and stimulation by hydrochloric acid and a synthetic prostaglandin El
-
Isenberg JI, Hogan DL, Koss MA, Selling JA. Human duodenal mucosal bicarbonate secretion. Evidence for basal secretion and stimulation by hydrochloric acid and a synthetic prostaglandin El. Gastroenterology 1986; 91: 370-378.
-
(1986)
Gastroenterology
, vol.91
, pp. 370-378
-
-
Isenberg, J.I.1
Hogan, D.L.2
Koss, M.A.3
Selling, J.A.4
-
9
-
-
0022317326
-
Conséquence de l'acidification antrale et duodénale sur le débit acide, la réponse gastrinique et la vidange gastrique chez l'ulcéreux duodénal et chez le sujet sain
-
Merrouche M, Mignon M, Rigaud D et al Conséquence de l'acidification antrale et duodénale sur le débit acide, la réponse gastrinique et la vidange gastrique chez l'ulcéreux duodénal et chez le sujet sain. Gastroentérol Clin Biol 1985; 9: 902-910.
-
(1985)
Gastroentérol Clin Biol
, vol.9
, pp. 902-910
-
-
Merrouche, M.1
Mignon, M.2
Rigaud, D.3
-
10
-
-
0026975672
-
Evidence for the interaction between antacid and gastric mucosa using an 'artificial stomach' model including gastric mucosa
-
Vatier J, Gao Z, Fu-Cheng XM et al. Evidence for the interaction between antacid and gastric mucosa using an 'artificial stomach' model including gastric mucosa. J Pharmacol Exp Ther 1992; 263: 1206-1211.
-
(1992)
J Pharmacol Exp Ther
, vol.263
, pp. 1206-1211
-
-
Vatier, J.1
Gao, Z.2
Fu-Cheng, X.M.3
-
12
-
-
0344055710
-
Over the counter drugs: Proposal for establishing a monograph for OTC antacid products
-
Over the counter drugs: proposal for establishing a monograph for OTC antacid products. Fed Reg 1973; 38: 8714-8724.
-
(1973)
Fed Reg
, vol.38
, pp. 8714-8724
-
-
-
14
-
-
0027062722
-
Importance de la formulation d'une forme galénique effervescente et incidence des excipients sur les potentialités pharmacologiques. Cas particulier des anti-H2
-
Jacob M, Mention J, Baylac G et al Importance de la formulation d'une forme galénique effervescente et incidence des excipients sur les potentialités pharmacologiques. Cas particulier des anti-H2. Med Chit Dig 1992; 21: 371-376.
-
(1992)
Med Chit Dig
, vol.21
, pp. 371-376
-
-
Jacob, M.1
Mention, J.2
Baylac, G.3
-
16
-
-
5844350047
-
Ranitidine 300 mg effervescente. Activité antiacide et pouvoir tampon liés au complexe effervescent
-
Vatier J, Slama A, Vitré MT, Mignon M. Ranitidine 300 mg effervescente. Activité antiacide et pouvoir tampon liés au complexe effervescent. Med Chir Dig 1992; 21: 467-470.
-
(1992)
Med Chir Dig
, vol.21
, pp. 467-470
-
-
Vatier, J.1
Slama, A.2
Vitré, M.T.3
Mignon, M.4
-
17
-
-
5844423100
-
Effervescent tablet ranitidine: Pharmacokinetic study of a new oral formulation
-
abstract
-
Alberola B, Aubert B, Cournot A. Effervescent tablet ranitidine: pharmacokinetic study of a new oral formulation. Therapie 1992; 47: 137 (abstract).
-
(1992)
Therapie
, vol.47
, pp. 137
-
-
Alberola, B.1
Aubert, B.2
Cournot, A.3
-
18
-
-
0009722599
-
Rapid absorption and hight plasma concentrations with the ranitidine effervescent formulation results in a very quick onset of action on the intragastric pH in volunteers
-
abstract P13
-
Devis G, De Rop H, Duville L, Van Avermaet S, Reynaert R, Michotte Y. Rapid absorption and hight plasma concentrations with the ranitidine effervescent formulation results in a very quick onset of action on the intragastric pH in volunteers. Scand J Gastroenterol 1993; 28 (suppl 197): 70 (abstract P13).
-
(1993)
Scand J Gastroenterol
, vol.28
, Issue.197 SUPPL.
, pp. 70
-
-
Devis, G.1
De Rop, H.2
Duville, L.3
Van Avermaet, S.4
Reynaert, R.5
Michotte, Y.6
|